An Alabama-based doctor pleaded guilty on Oct. 1, 2025, in federal court in Boston to participating in a $6 million telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME) and genetic testing used to identify potential cancer-related gene mutations.
Between December 2018 and March 2021, the doctor worked with telemedicine companies to sign pre-populated medical documentation, including doctors’ orders for DME and genetic testing. These orders were generated through telemarketing calls with Medicare beneficiaries, whom the doctor generally did not examine, contact, or have any medical relationship with.
DME suppliers and laboratories used the signed orders to submit claims to Medicare. As a result of the doctor’s participation, more than $6 million in claims were submitted for medically unnecessary equipment and tests based on false or kickback-tainted documentation.
The healthcare fraud charge carries a maximum sentence of up to 10 years in prison and up to three years of supervised release. It also includes a potential fine of $250,000 or twice the gross financial gain or loss, whichever is greater.
Compliance Perspective
Issue
Telemedicine has become a standard mode of care delivery across many healthcare settings, offering increased access and efficiency. However, its expanded use continues to present compliance risks—particularly when providers sign orders for DME or laboratory testing without a valid clinical relationship or documented medical necessity. Such practices may lead to the submission of false claims and expose providers and organizations to liability under the False Claims Act, Anti-Kickback Statute, and other federal regulations. Organizations must ensure telemedicine services are delivered in accordance with applicable laws and accepted standards of care.
Discussion Points
- Review policies and procedures to ensure that all telemedicine services are supported by documented clinical evaluations, valid practitioner-patient relationships, and independent medical judgment. If needed, consider engaging an external consultant to assist with policy development or conduct a focused review of current protocols to ensure they meet regulatory standards.
- Provide regular training to staff on the appropriate use of telemedicine, fraud prevention, and documentation standards. Med-Net Academy offers Fraud Module 10 – Vendor Contracts, which covers adherence to vendor contracting policies, Medicare billing requirements, and government contracting elements.
- Conduct periodic audits of telemedicine services, including DME and lab orders, to identify potential compliance concerns and ensure all claims are properly supported. Audits can be supplemented with periodic evaluations performed by an independent consultant, particularly one experienced in conducting mock surveys or targeted reviews, to help identify potential vulnerabilities and strengthen ongoing compliance efforts.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*